FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileEli Lilly and Company
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LLY.TO
Eli Lilly and Company Stock AnalysisComprehensive stock analysis for Eli Lilly and Company (LLY.TO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLLY.TO
LLY.TO
Eli Lilly and Company
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LLY.TO
  1. Home
  2. Stocks
  3. Eli Lilly and Company

Eli Lilly and Company

🇨🇦LLY.TO•TSX

Eli Lilly and Company

🇨🇦LLY.TO•TSX
Market cap
$1.70T
P/E ratio
44.92

Your view on LLY.TO

Mkt Cap
$1.70T
P/E
44.92
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Eli Lilly and Company

Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
David A. Ricks
Headquarters
P.O. Box 73, Exchange Tower 130 King Street West, Suite 900, Indianapolis, IN, US
Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
David A. Ricks
Headquarters
P.O. Box 73, Exchange Tower 130 King Street West, Suite 900, Indianapolis, IN, US
Description

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Eli Lilly and Company. Starting points for Eli Lilly and Company: P/E 44.9, EPS C$30.92, beta 1.19 — an Drug Manufacturers - General name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Eli Lilly and Company. Eli Lilly and Company paid C$0.25 per share over the last year — a 0.5% yield at the current C$49.16 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Eli Lilly and Company. Trailing twelve-month EPS for Eli Lilly and Company stands at C$30.92. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Eli Lilly and Company. Eli Lilly and Company has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold LLY.TO12 companies · 6 funds
More Drug Manufacturers - General companies
TickerTypeCompanySectorExchangeMkt cap
JNJJohnson & JohnsonHealthcareNYSE$656.5B
LLYEli Lilly and CompanyHealthcareNYSE$1.3T
MIRAMIRA Pharmaceuticals, Inc.HealthcareNASDAQ$24.8M
MRKMerck & Co., Inc.HealthcareNYSE$339.7B
NONOFNovo Nordisk A/SHealthcareOTC$168.6B
NVONovo Nordisk A/SHealthcareNYSE$173.8B
NVSNovartis AGHealthcareNYSE$293.1B
NVSEFNovartis AGHealthcareOTC$316.8B
OGNOrganon & Co.HealthcareNYSE$3.7B
OPHLFOno Pharmaceutical Co., Ltd.HealthcareOTC$7.8B
OPHLYOno Pharmaceutical Co., Ltd.HealthcareOTC$7.9B
ORINFOrion OyjHealthcareOTC$11.1B
ETFs holding Eli Lilly and Company
TickerFundFund assets% of the fund
PBPHPortfolio Building Block World Pharma and Biotech Index ETF$1.4B in assets16.94%
TGRTT. Rowe Price Growth ETF$1.6B in assets3.54%
DXG.TODynamic Active Global Dividend ETF$825M in assets1.93%
VUN.TOVanguard U.S. Total Market Index ETF$20.1B in assets0.00%
DXU.TODynamic Active U.S. Dividend ETF$85M in assets3.80%
VEQT.TOVanguard All-Equity ETF Portfolio$17.6B in assets0.00%

Largest holders first, then the funds most concentrated in LLY.TO.

Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Eli Lilly and Company. Coverage tracks Eli Lilly and Company within Drug Manufacturers - General (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Eli Lilly and Company.

LLY.TO AnalysisWeak
Past
4
Growth
0
Health
3
Profit
0
Value
1

News

Latest Market News